Seasonal influenza is a major global health threat, causing significant morbidity and mortality annually and placing stress on health systems worldwide. Influenza vaccination programs play a critical role in reducing the burden of influenza epidemics and enhancing pandemic preparedness, including for other respiratory pathogens like COVID-19. In July 2024, WHO convened a 3-day meeting to strengthen seasonal influenza vaccination policies and programs. Sessions focused on the current global landscape, charting high-level actions for global progress, and operational planning for the Global Influenza Strategy. Key takeaways emphasized coordinated global efforts, tailored approaches, improved data and evidence, and public–private collaboration to advance influenza vaccination programs.

This guidance is an update of WHO global influenza preparedness plan: the role of WHO and recommendations for national measures before and during pandemics, published March 2005 (WHO/CDS/CSR/GIP/2005.5).

The New Zealand Influenza Pandemic Plan: A framework for action sets out the all-of-government measures to be taken to prepare for and respond to an influenza pandemic. It replaces the New Zealand Influenza Pandemic Action Plan 2006. Pandemics by their nature are unpredictable in terms of timing, severity and the population groups that are most affected. This version of the New Zealand Influenza Pandemic Plan establishes a framework for action that can readily be adopted and applied to any pandemic, irrespective of the nature of the virus and its severity.

The 2009 H1N1 vaccination campaign was one of the largest public health campaigns in U.S. history, vaccinating one-quarter of the population in the first three months. The Institute of Medicine held three workshops in Raleigh, NC; Austin, TX; and Seattle, WA to learn from participants' experiences during the campaign and improve future emergency vaccination programs.

Vaccination is a fundamental component of preventive medicine and public health. The use of vaccines to prevent infectious diseases has resulted in dramatic decreases in disease, disability, and death in the United States and around the world. The current political, economic, and social environment presents both opportunities for and challenges to strengthening the U.S. system for developing, manufacturing, regulating, distributing, funding, and administering safe and effective vaccines for all people. Priorities for the National Vaccine Plan examines the extraordinarily complex vaccine enterprise, from research and development of new vaccines to financing and reimbursement of immunization services. Priorities for the National Vaccine Plan examines the extraordinarily complex vaccine enterprise, from research and development of new vaccines to financing and reimbursement of immunization services. The book makes recommendations about priority actions in the update to the National Vaccine Plan that are intended to achieve the objectives of disease prevention and enhancement of vaccine safety. It is centered on the plan's five goals in the areas of vaccine development, safety, communication, supply and use, and global health.

This report describes the current situation with regard to universal health coverage and global quality of care, and outlines the steps governments, health services and their workers, together with citizens and patients need to urgently take.